Dobrin Draganov
Biomarker and Precision Medicine Lead, Translational Medicine Unit (TMU) at Sanofi
- Role
- Clinical Biomarker Lead, Translational Medicine Early Development (Tmed) Oncology at Sanofi
- Location
- San Diego, CA, US
- LinkedIn followers
- 500 followers
Healthcare & Human ServicesView LinkedIn profile
Experience
Clinical Biomarker Lead, Translational Medicine Early Development (Tmed) Oncology
Dec 2020 — Present · Cambridge, MA, US
Education
Harvard University
Doctor of Philosophy (PhD)
2002 — 2012
Harvard Medical School
Doctor of Philosophy (PhD)
2002 — 2011
Massachusetts Institute of Technology
BS
1999 — 2002
Skills
- Life Sciences
- In Vivo
- Cell Culture
- Cell
- Molecular Cloning
- Animal Models
- Biochemistry
- Tissue Culture
- Biotechnology
- Mammalian Cell Culture
- Vaccines
- Molecular Biology
- Immunohistochemistry
- Qpcr
- Elisa
- Cell Biology
- Immunofluorescence
- Lifesciences
- Protein Expression
- Flow Cytometry
- Immunology
- Rt-Pcr
- Western Blotting
- Transfection
- Pcr
- Cancer Research
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.